Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021
© 2021. The Author(s)..
A growing number of emerging SARS-CoV-2 variants is being identified worldwide, potentially impacting the effectiveness of current vaccines. We report the data obtained in several Italian regions involved in the SARS-CoV-2 variant monitoring from the beginning of the epidemic and spanning the period from October 2020 to March 2021.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Virology journal - 18(2021), 1 vom: 14. Aug., Seite 168 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
COVID-19 RT-PCR testing |
---|
Anmerkungen: |
Date Completed 25.08.2021 Date Revised 29.11.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12985-021-01638-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329352008 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329352008 | ||
003 | DE-627 | ||
005 | 20231225204928.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12985-021-01638-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329352008 | ||
035 | |a (NLM)34391446 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lai, Alessia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.08.2021 | ||
500 | |a Date Revised 29.11.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s). | ||
520 | |a A growing number of emerging SARS-CoV-2 variants is being identified worldwide, potentially impacting the effectiveness of current vaccines. We report the data obtained in several Italian regions involved in the SARS-CoV-2 variant monitoring from the beginning of the epidemic and spanning the period from October 2020 to March 2021 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 RT-PCR testing | |
650 | 4 | |a Complete genome sequencing | |
650 | 4 | |a SARS-CoV-2 virus | |
650 | 4 | |a Spike protein | |
650 | 4 | |a Viral variants | |
700 | 1 | |a Bergna, Annalisa |e verfasserin |4 aut | |
700 | 1 | |a Menzo, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Zehender, Gianguglielmo |e verfasserin |4 aut | |
700 | 1 | |a Caucci, Sara |e verfasserin |4 aut | |
700 | 1 | |a Ghisetti, Valeria |e verfasserin |4 aut | |
700 | 1 | |a Rizzo, Francesca |e verfasserin |4 aut | |
700 | 1 | |a Maggi, Fabrizio |e verfasserin |4 aut | |
700 | 1 | |a Cerutti, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Giurato, Giorgio |e verfasserin |4 aut | |
700 | 1 | |a Weisz, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Turchi, Chiara |e verfasserin |4 aut | |
700 | 1 | |a Bruzzone, Bianca |e verfasserin |4 aut | |
700 | 1 | |a Ceccherini Silberstein, Francesca |e verfasserin |4 aut | |
700 | 1 | |a Clementi, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Callegaro, Annapaola |e verfasserin |4 aut | |
700 | 1 | |a Sagradi, Fabio |e verfasserin |4 aut | |
700 | 1 | |a Francisci, Daniela |e verfasserin |4 aut | |
700 | 1 | |a Venanzi Rullo, Emmanuele |e verfasserin |4 aut | |
700 | 1 | |a Vicenti, Ilaria |e verfasserin |4 aut | |
700 | 1 | |a Clementi, Massimo |e verfasserin |4 aut | |
700 | 1 | |a Galli, Massimo |e verfasserin |4 aut | |
700 | 0 | |a collaborative group SCIRE SARS-CoV-2 Italian Research Enterprise |e verfasserin |4 aut | |
700 | 1 | |a Balotta, Claudia |e investigator |4 oth | |
700 | 1 | |a Gori, Maria |e investigator |4 oth | |
700 | 1 | |a Bagnarelli, Patrizia |e investigator |4 oth | |
700 | 1 | |a Baj, Andreina |e investigator |4 oth | |
700 | 1 | |a Novazzi, Federica |e investigator |4 oth | |
700 | 1 | |a Orsi, Andrea |e investigator |4 oth | |
700 | 1 | |a Caligiuri, Patrizia |e investigator |4 oth | |
700 | 1 | |a Boccotti, Simona |e investigator |4 oth | |
700 | 1 | |a Bellocchi, Maria Concetta |e investigator |4 oth | |
700 | 1 | |a Sarmati, Loredana |e investigator |4 oth | |
700 | 1 | |a Andreoni, Massimo |e investigator |4 oth | |
700 | 1 | |a Mancini, Nicasio |e investigator |4 oth | |
700 | 1 | |a Criscuolo, Elena |e investigator |4 oth | |
700 | 1 | |a Gallitelli, Rosa |e investigator |4 oth | |
700 | 1 | |a Testa, Sophie |e investigator |4 oth | |
700 | 1 | |a Dragoni, Filippo |e investigator |4 oth | |
700 | 1 | |a Zazzi, Maurizio |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Virology journal |d 2004 |g 18(2021), 1 vom: 14. Aug., Seite 168 |w (DE-627)NLM151772509 |x 1743-422X |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2021 |g number:1 |g day:14 |g month:08 |g pages:168 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12985-021-01638-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2021 |e 1 |b 14 |c 08 |h 168 |